{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:43:31Z","timestamp":1782737011981,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmc.2021.116159","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:03:37Z","timestamp":1618790617000},"page":"116159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["A trio of quinoline-isoniazid-phthalimide with promising antiplasmodial potential: Synthesis, in-vitro evaluation and heme-polymerization inhibition studies"],"prefix":"10.1016","volume":"39","author":[{"given":"Anu","family":"Rani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Legac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116159_b0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2021.116159_b0010","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019. https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2019\/en\/."},{"key":"10.1016\/j.bmc.2021.116159_b0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/138161213804070302","article-title":"The need for new antimalarial drugs less prone to resistance","volume":"19","author":"Noedl","year":"2013","journal-title":"Curr Pharm Des"},{"key":"#cr-split#-10.1016\/j.bmc.2021.116159_b0020.1","doi-asserted-by":"crossref","unstructured":"(a) Kouznetsov VV, Gomez-Barrio A. Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation. Eur J Med Chem 2009","DOI":"10.1002\/chin.200937226"},{"key":"#cr-split#-10.1016\/j.bmc.2021.116159_b0020.2","doi-asserted-by":"crossref","unstructured":"2016. p. 383-407. (d) de Walle TV, Boone M, Puyvelde JV, et al. Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents. Eur J Med Chem 2020","DOI":"10.1016\/j.ejmech.2020.112330"},{"key":"#cr-split#-10.1016\/j.bmc.2021.116159_b0020.3","doi-asserted-by":"crossref","unstructured":"(a) Kouznetsov VV, Gomez-Barrio A. Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation. Eur J Med Chem 2009; 44: 3091-113.","DOI":"10.1016\/j.ejmech.2009.02.024"},{"key":"#cr-split#-10.1016\/j.bmc.2021.116159_b0020.4","doi-asserted-by":"crossref","unstructured":"(b) Smithson DC, Guiguemde WA, Guy RK. Antimalarials. In: Abraham DJ, editor. Burger's medicinal chemistry and drug discovery; 2010.","DOI":"10.1002\/0471266949.bmc234"},{"key":"#cr-split#-10.1016\/j.bmc.2021.116159_b0020.5","doi-asserted-by":"crossref","unstructured":"(c) Shah NK, Valecha N. Antimalarial drug resistance. In: Gaur D, Chitnis DE, Chauhan VS, editors. Advances in malaria research; 2016. p. 383-407.","DOI":"10.1002\/9781118493816.ch14"},{"key":"#cr-split#-10.1016\/j.bmc.2021.116159_b0020.6","doi-asserted-by":"crossref","unstructured":"(d) de Walle TV, Boone M, Puyvelde JV, et al. Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents. Eur J Med Chem 2020; 198: 112330.","DOI":"10.1016\/j.ejmech.2020.112330"},{"key":"10.1016\/j.bmc.2021.116159_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-13-339","article-title":"Recent progress in the development of anti-malarial quinolones","volume":"13","author":"Beteck","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2021.116159_b0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116159_b0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study","volume":"15","author":"Spring","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2021.116159_b0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3201\/eid2304.161872","article-title":"Treatment failure of dihydroartemisinin\/piperaquine for Plasmodium falciparum malaria","volume":"23","author":"Phuc","year":"2017","journal-title":"Vietnam Emerg Infect Dis"},{"key":"10.1016\/j.bmc.2021.116159_b0045","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/ncomms6606","article-title":"Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using modelbased cost-effectiveness analysis","volume":"5","author":"Okell","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2021.116159_b0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000252658","article-title":"Pharmacokinetic and toxicological profile of artemisinin compounds: an update","volume":"84","author":"Medhi","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.bmc.2021.116159_b0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116159_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/138955708783744092","article-title":"Malaria combination therapies: advantages and shortcomings","volume":"8","author":"Martinelli","year":"2008","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_b0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pt.2008.09.005","article-title":"Recent highlights in antimalarial drug resistance and chemotherapy research","volume":"24","author":"Fidock","year":"2008","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2021.116159_h0070","first-page":"1071","article-title":"Malaria transmission-blocking drugs: implications and future","volume":"12","author":"Wadi","year":"2020","journal-title":"perspectivesFuture Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-13-339","article-title":"D.D N\u2019Da Recent progress in the development of anti-malarial quinolones","volume":"13","author":"Beteck","year":"2014","journal-title":"Malaria J"},{"key":"10.1016\/j.bmc.2021.116159_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"4","author":"Meunier","year":"2008","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2021.116159_b0080","first-page":"1","article-title":"Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"42","author":"Muregi","year":"2009","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2021.116159_b0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.11.021","article-title":"N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies","volume":"162","author":"Maurya","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_b0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ejmech.2016.11.057","article-title":"Design, synthesis and evaluation of 4-aminoquinoline-purine hybrids as potential antiplasmodial agents","volume":"126","author":"Reddy","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jinorgbio.2013.08.007","article-title":"Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: Effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool","volume":"129","author":"Walcourt","year":"2013","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2021.116159_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/14756366.2011.575071","article-title":"Synthesis and biological screening of some pyridine derivatives as anti-malarial agents","volume":"27","author":"Bekhit","year":"2012","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0110","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/138955710791572442","article-title":"Recent advances in the chemistry of phthalimide analogues and their therapeutic potential","volume":"10","author":"Sharma","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0115","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bmc.2015.02.029","article-title":"Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite","volume":"23","author":"Singh","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejmech.2017.11.033","article-title":"Microwave-promoted facile access to 4-aminoquinoline-phthalimides: Synthesis and anti-plasmodial evaluation","volume":"143","author":"Rani","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0125","doi-asserted-by":"crossref","first-page":"102912","DOI":"10.1016\/j.bioorg.2019.04.006","article-title":"Substituted 1,3-dioxoisoindoline-4-Aminoquinolines coupled via amide linkers: Synthesis, antiplasmodial and cytotoxic evaluation","volume":"88","author":"Rani","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/fmc-2019-0260","article-title":"Design, synthesis, heme binding and density functional theory studies of isoindoline-dione-4-aminoquinolines as potential antiplasmodials","volume":"12","author":"Rani","year":"2019","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2021.116159_h0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/acsmedchemlett.9b00521","article-title":"Kumar, Functionalized naphthalimide-4-aminoquinoline conjugates as promising antiplasmodials, with mechanistic insights","volume":"11","author":"Shalini","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116159_h0140","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/acsmedchemlett.0c00536","article-title":"Kumar, Amide Tethered 4-Aminoquinoline-naphthalimide Hybrids: A New Class of Possible Dual Function Antiplasmodials","volume":"11","author":"Shaini","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116159_h0145","doi-asserted-by":"crossref","first-page":"126810","DOI":"10.1016\/j.bmcl.2019.126810","article-title":"Synthesis, anti-plasmodial and cytotoxic evaluation of 1H\u20131,2,3-triazole\/acyl hydrazide integrated tetrahydro-\u03b2-carboline-4-aminoquinoline conjugates","volume":"30","author":"Sharma","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116159_h0150","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.13738","article-title":"Amalgamating Isatin\/Indole\/Nitroimidazole with 7-chloroquinolines via azide-alkyne cycloaddition: Synthesis, anti-plasmodial, and cytotoxic evaluation","author":"Kumar","year":"2020","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2021.116159_h0155","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cbdd.12982","article-title":"Piperazine-linked 4-aminoquinoline-chalcone\/ferrocenyl-chalcone conjugates: Synthesis and antiplasmodial evaluation","volume":"90","author":"Singh","year":"2017","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2021.116159_b0120","doi-asserted-by":"crossref","first-page":"127576","DOI":"10.1016\/j.bmcl.2020.127576","article-title":"Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials","volume":"30","author":"Rani","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116159_b0125","unstructured":"http:\/\/www.molinspiration.com\/cgi-bin\/properties."},{"key":"10.1016\/j.bmc.2021.116159_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molcata.2011.12.011","article-title":"Experimental design and MM2-PM6 molecular modelling of hematin as a peroxidase-like catalyst in Alizarin Red S degradation","volume":"355","author":"C\u00f3rdoba","year":"2012","journal-title":"J Mol Catal A Chem"},{"key":"10.1016\/j.bmc.2021.116159_b0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","article-title":"Quinoline\u2212pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies","volume":"57","author":"Singh","year":"2014","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962100167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962100167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:12:44Z","timestamp":1760836364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962100167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":40,"alternative-id":["S096808962100167X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116159","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A trio of quinoline-isoniazid-phthalimide with promising antiplasmodial potential: Synthesis, in-vitro evaluation and heme-polymerization inhibition studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116159"}}